For the quantitative detection of Human CTX-II
CTX-II is a biomarker for type II collagen degradation, which is mainly found in cartilage. It is a small peptide fragment that is released into the synovial fluid and blood when there is cartilage degradation. CTX-II has been extensively studied as a diagnostic and prognostic marker for osteoarthritis, and it has also been shown to be a useful tool for monitoring the efficacy of treatments targeting cartilage degradation. The structure of CTX-II is a small peptide consisting of 17 amino acids. It is derived from the C-terminal telopeptide of type II collagen. CTX-II functions as a biomarker for cartilage degradation and can be used to monitor the progression of osteoarthritis and the effectiveness of treatments.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-106425 |
| Réf. fabricant | 18057464 |
| Plage de dosage | 0.16 to 10 ng/mL |
| Sensibilité du dosage | 0.1 ng/mL |
| Conjugué | HRP |
| Type de produit | ELISA |
| Type d’échantillon | Serum |
| À utiliser avec (équipement) | Colorimetric Microplate Reader |
| Coefficient de variation inter-dosage | <10% |
| Coefficient de variation intra-dosage | <10% |
| Contenus des kits | Pre-coated 96 well plate, Standard, Biotinylated Detection Antibody, HRP Conjugate, Standard & Sample Diluent, Biotinylated Detection Antibody Diluent, HRP Conjugate Diluent, Wash Buffer, TMB Substrate, Stop Solution, Plate Sealer |
| Marqueur ou colorant | HRP |
| Quantité | 96 Tests |
| État réglementaire | RUO |
| Volume d’échantillon | 100 µL |
| Conditions de stockage | Refer to product documentation for component specific storage temperature. |
| Cible | Human |
| Heure du test | 1 hr 20 min |
| Durée totale du dosage | 3 hr 30 min |
